Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
about
Radiation Therapy after Radical Prostatectomy: Implications for CliniciansA comprehensive review of contemporary role of local treatment of the primary tumor and/or the metastases in metastatic prostate cancerSurgical resection of urological tumor metastases following medical treatmentPET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Salvage radiotherapy for patients with PSA relapse following radical prostatectomy: issues and challenges.Evaluation of 11C-choline PET/CT for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract: a pilot studyNovel tracers and their development for the imaging of metastatic prostate cancer.Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.Metabolomics: a novel approach to early and noninvasive prostate cancer detection.Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review.Debulking surgery in the setting of very high-risk prostate cancer scenarios.Individualized image-based lymph node irradiation for prostate cancer.A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.The clinical role of multimodality imaging in the detection of prostate cancer recurrence after radical prostatectomy and radiation therapy: past, present, and futurePatterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.Influence of (11)C-choline PET/CT on radiotherapy planning in prostate cancer.The Role of C-Choline-PET/CT-Guided Secondary Lymphadenectomy in Patients with PSA Failure after Radical Prostatectomy: Lessons Learned from Eight Cases.3D Prostate Segmentation of Ultrasound Images Combining Longitudinal Image Registration and Machine LearningComplete PSA Remission without Adjuvant Therapy after Secondary Lymph Node Surgery in Selected Patients with Biochemical Relapse after Radical Prostatectomy and Pelvic Lymph Node Dissection.[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.A Molecular Image-directed, 3D Ultrasound-guided Biopsy System for the ProstatePET-directed, 3D Ultrasound-guided prostate biopsy.Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.Selective lymph node dissection for castration-resistant prostate cancer.Molecular imaging and fusion targeted biopsy of the prostate.11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer.Is there a role for salvage lymphadenectomy as second line therapy post robotic radical prostatectomy?Robotic salvage retroperitoneal and pelvic lymph node dissection for 'node-only' recurrent prostate cancer: technique and initial series.The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.[11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.Correlation of metabolic tumor volume and 11C-choline uptake with the pathology of prostate cancer: evaluation by use of simultaneously recorded MR and PET images.Is there a role for salvage lymphadenectomy as second-line therapy post-robotic radical prostatectomy?Toxicity and outcome of pelvic IMRT for node-positive prostate cancer.[Resection of metastases from prostate cancer].[Salvage lymphadenectomy in patients with prostate cancer recurrence: A review].Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment.
P2860
Q26744531-34D40357-CA8B-4BC8-A332-8EFC138BC0BFQ27000180-A0AAEAD8-B3EC-402B-9529-D9870F9E1E89Q27013035-CBB4D1C6-FA36-4997-B794-14AF0D3F35A4Q31003607-AEFC6602-FA84-4A01-B1EF-7F4E07D83ED1Q33766462-08A406F3-2E73-4F3C-8CD3-C5723CC1D6C8Q34485009-04FE77F7-FE19-4337-8C9F-C4CD8E87A5A8Q37321810-F1AB3BD5-9666-4BD8-AAEF-87AC6EF2498BQ37457888-88B0B0D7-E356-44EA-88ED-3CC534247A2AQ37850315-8595D858-9857-4C9E-85ED-EBC85D5D5EA9Q37973351-552DAF3B-8802-4BEE-BD03-B5DB556633E9Q37982152-D28A54F1-0B50-4D24-A1B2-BDF2B208C339Q38109812-6F7EA70C-C7D3-4EF1-92F6-38606D370EB4Q38190115-44B33F2E-AF89-47C9-9E9C-31ADF303E649Q38191927-9352D6FE-F4C4-44E3-83EF-FBD91FDB9497Q38802235-9B90AADC-3692-4F4B-969B-471A25D1B7D9Q38956835-D85A8CD1-D425-4F96-A995-377537C0C61CQ38996907-401BA352-7698-4E96-BEE5-3A22D5226F98Q41094016-FD592BF7-074A-478B-8745-7D25E64F0097Q41860365-6937A4CF-B719-4227-987D-B0F2E0F64884Q41903056-AE838E62-FD49-4565-BB00-1C98D775501DQ41959689-6D835EB9-DF6D-4C27-A7C4-80AFF5720302Q42072377-828FF0C3-5933-4376-A244-95E44A0CECB9Q42202139-18BE2C37-5DBC-4083-A09D-EBEF9E72391AQ42991361-C79866E5-DA3C-4A4B-B26D-85C8645C2C7EQ45346212-A1FDC8B0-87D0-47F4-B3A9-FA0764338EE5Q46143507-6B66B115-18DE-4918-9200-C7E2A4B56F9BQ47608215-7E42E989-AEE5-44CB-B3EE-A59D2EE5C54CQ47693880-3B5DE425-8410-4625-8147-382738705ACFQ50665259-9AF3CDB8-B75D-46EA-AE03-4854E9428CC4Q51008062-13A85672-2C99-441F-BED7-D306F431D8CBQ51073020-05509D22-CD6F-45D2-9B04-F351BA33C26DQ52983467-743CAD7F-81AB-47F1-A251-8EE9DA1A6831Q52984262-FA8EF849-3B46-4008-A3B6-0AE6AA11A9DBQ53060499-EC09A2E0-B189-4278-BBE7-73A98E46C9E1Q53082630-128C1637-96C3-4EA8-9BD1-1B4640B63454Q53130316-016CED59-7DFB-48AF-9A1C-C2376DFC4745Q53137626-B1791E4E-E89D-4995-A7F5-1E2F72D32524Q53173958-579ADA73-5496-4ACD-83F5-154576066558Q53804889-C6EEE419-2FE9-460A-9F3C-6B2F1C9271FFQ55188040-DDD73663-5EA3-4608-8D45-C55ADC23AA94
P2860
Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Histological verification of 1 ...... for localized prostate cancer.
@en
Histological verification of 1 ...... for localized prostate cancer.
@nl
type
label
Histological verification of 1 ...... for localized prostate cancer.
@en
Histological verification of 1 ...... for localized prostate cancer.
@nl
prefLabel
Histological verification of 1 ...... for localized prostate cancer.
@en
Histological verification of 1 ...... for localized prostate cancer.
@nl
P2093
P1433
P1476
Histological verification of 1 ...... for localized prostate cancer.
@en
P2093
Arnulf Stenzl
Axel S Merseburger
Christa Pfannenberg
David Schilling
Heinz P Schlemmer
Patrick Böttcher
Philip Aschoff
Philipp H Wagner
Roland Bares
Stefan Corvin
P304
P356
10.1111/J.1464-410X.2008.07592.X
P577
2008-04-11T00:00:00Z